Green Card Product Development Intern Jobs
Product Development Intern roles can qualify for EB-2 or EB-3 green card sponsorship through the PERM labor certification process, where your employer demonstrates no qualified U.S. workers are available. Sponsorship at the intern level is uncommon but real, particularly at large R&D-driven companies with established immigration programs.
Find Green Card Product Development Intern JobsOverview
Showing 5 of 10,403+ Product Development Intern jobs
See all 10,403+ Product Development Intern Jobs
Sign up for free to unlock all listings, filter by visa type, and get alerts for new Product Development Intern roles.
Get Access To All JobsCompany Overview:
Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is leveraging its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated, one-time, potentially curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types. Prime Medicine is currently progressing a diversified portfolio of investigational therapeutic programs organized around our core areas of focus: hematology, immunology & oncology, liver and lung. Across each core area, Prime Medicine is focused initially on a set of high value programs, each targeting a disease with well-understood biology and a clearly defined clinical development and regulatory path, and each expected to provide the foundation for expansion into additional opportunities. Prime Medicine is a clinical-stage biotechnology company pioneering Prime Editing, a novel and precise "search-and-replace" gene editing technology capable of correcting the vast majority of disease-causing genetic mutations. Our approach allows us to make virtually any type of genetic edit — insertions, deletions, and all base-to-base conversions — without introducing double-strand breaks or requiring a separate donor DNA template. We are advancing a broad pipeline of Prime Editing–based therapies, including in vivo liver-directed programs and ex vivo approaches for ultra-rare disease, with a mission to develop one-time, curative genetic therapies for patients with limited or no treatment options today.
Position Overview
Location: Cambridge, MA (hybrid — min. 3-days a week onsite)
Reports to: VP, Programs and Strategy
Level: VP
Prime Medicine is seeking an experienced, strategic, and operationally rigorous Development Asset Leader to assume leadership of our in vivo LNP-delivered liver programs as they advance from early clinical development through licensure, beginning with our Wilson's Disease and Alpha-1 Antitrypsin Deficiency programs. The Asset Leader will step in seamlessly once a liver program has cleared IND and owns the asset through clinical PoC and regulatory approval/licensure. As Prime's liver portfolio grows, this leader is expected to scale from single-asset ownership into a franchise-level leadership capability, building the processes, governance, and team structure to efficiently deploy our capital to advance multiple concurrent clinical assets. The ideal candidate is equally comfortable engaging with both internal (executive management and Board) and external (regulatory authorities, KOLs, CRO/CDMO leadership) stakeholders as they are running a cohesive cross-functional team, building genuine esprit de corps across a lean organization while holding the asset accountable to timeline, budget, and scientific rigor.
Primary Responsibilities
- Own the Integrated Development Plan for liver assets from IND acceptance through regulatory approval/licensure, including trial design input, data package strategy, and key go/no-go decision points
- Anticipate, frame, and escalate the critical considerations that materially change the asset's risk/value profile to executive management
- Lead a matrixed team spanning Clinical, Regulatory, CMC/Manufacturing, Biostatistics, Pharmacovigilance, Med Affairs/Patient Advocacy, and Commercial
- Deploy, where appropriate, AI-enabled project management tooling (timelines, risk registers, cross-functional dashboarding)
- As the liver franchise expands, help design the team structure, governance cadence, and knowledge-transfer processes to advance Prime’s portfolio
- Serve as a key point of contact with CROs/CDMOs, KOLs, and patient advocacy groups for the asset, and represent the asset in regulatory interactions alongside Regulatory Affairs
Preferred Qualifications
- Advanced degree in life sciences, medicine, or related field (PhD, MD, PharmD) preferred; equivalent industry experience considered
- 12+ years of drug development experience in biotech/pharma, with demonstrated leadership of a clinical-stage asset from IND through late-stage development
- Direct experience in genetic medicines (gene/gene editing therapies, RNA-based therapeutics) or rare disease preferred; liver-directed or LNP delivery experience a strong plus
- Track record of cross-functional program leadership and accountability spanning Clinical, Regulatory, CMC, and Nonclinical
- Demonstrated ability to influence without formal authority, build team culture, and manage external partners (consultants, CROs, KOLs) as an extension of the internal team
- Experience or genuine interest in applying AI tools to project/portfolio management
- Comfort operating in a lean, resource-constrained organization where the Asset Leader is expected to build capability
The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus) and an annual long-term incentive award (e.g., equity). Prime Medicine offers a comprehensive Total Rewards package with robust health, financial, and wellness benefits—including medical, dental, vision, life insurance, a 401(k) match, and equity programs—along with generous paid time off, wellness days, and company-wide recharge breaks. Our commitment to employee well-being reflects our belief that when we care for our people, we strengthen our ability to put patients first and make meaningful impact together.
U.S. Pay Range $360,000—$408,000 USD
Prime Medicine is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, sexual orientation, gender identity, disability, veteran status, or any other classification protected by law.
Company Overview:
Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is leveraging its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated, one-time, potentially curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types. Prime Medicine is currently progressing a diversified portfolio of investigational therapeutic programs organized around our core areas of focus: hematology, immunology & oncology, liver and lung. Across each core area, Prime Medicine is focused initially on a set of high value programs, each targeting a disease with well-understood biology and a clearly defined clinical development and regulatory path, and each expected to provide the foundation for expansion into additional opportunities. Prime Medicine is a clinical-stage biotechnology company pioneering Prime Editing, a novel and precise "search-and-replace" gene editing technology capable of correcting the vast majority of disease-causing genetic mutations. Our approach allows us to make virtually any type of genetic edit — insertions, deletions, and all base-to-base conversions — without introducing double-strand breaks or requiring a separate donor DNA template. We are advancing a broad pipeline of Prime Editing–based therapies, including in vivo liver-directed programs and ex vivo approaches for ultra-rare disease, with a mission to develop one-time, curative genetic therapies for patients with limited or no treatment options today.
Position Overview
Location: Cambridge, MA (hybrid — min. 3-days a week onsite)
Reports to: VP, Programs and Strategy
Level: VP
Prime Medicine is seeking an experienced, strategic, and operationally rigorous Development Asset Leader to assume leadership of our in vivo LNP-delivered liver programs as they advance from early clinical development through licensure, beginning with our Wilson's Disease and Alpha-1 Antitrypsin Deficiency programs. The Asset Leader will step in seamlessly once a liver program has cleared IND and owns the asset through clinical PoC and regulatory approval/licensure. As Prime's liver portfolio grows, this leader is expected to scale from single-asset ownership into a franchise-level leadership capability, building the processes, governance, and team structure to efficiently deploy our capital to advance multiple concurrent clinical assets. The ideal candidate is equally comfortable engaging with both internal (executive management and Board) and external (regulatory authorities, KOLs, CRO/CDMO leadership) stakeholders as they are running a cohesive cross-functional team, building genuine esprit de corps across a lean organization while holding the asset accountable to timeline, budget, and scientific rigor.
Primary Responsibilities
- Own the Integrated Development Plan for liver assets from IND acceptance through regulatory approval/licensure, including trial design input, data package strategy, and key go/no-go decision points
- Anticipate, frame, and escalate the critical considerations that materially change the asset's risk/value profile to executive management
- Lead a matrixed team spanning Clinical, Regulatory, CMC/Manufacturing, Biostatistics, Pharmacovigilance, Med Affairs/Patient Advocacy, and Commercial
- Deploy, where appropriate, AI-enabled project management tooling (timelines, risk registers, cross-functional dashboarding)
- As the liver franchise expands, help design the team structure, governance cadence, and knowledge-transfer processes to advance Prime’s portfolio
- Serve as a key point of contact with CROs/CDMOs, KOLs, and patient advocacy groups for the asset, and represent the asset in regulatory interactions alongside Regulatory Affairs
Preferred Qualifications
- Advanced degree in life sciences, medicine, or related field (PhD, MD, PharmD) preferred; equivalent industry experience considered
- 12+ years of drug development experience in biotech/pharma, with demonstrated leadership of a clinical-stage asset from IND through late-stage development
- Direct experience in genetic medicines (gene/gene editing therapies, RNA-based therapeutics) or rare disease preferred; liver-directed or LNP delivery experience a strong plus
- Track record of cross-functional program leadership and accountability spanning Clinical, Regulatory, CMC, and Nonclinical
- Demonstrated ability to influence without formal authority, build team culture, and manage external partners (consultants, CROs, KOLs) as an extension of the internal team
- Experience or genuine interest in applying AI tools to project/portfolio management
- Comfort operating in a lean, resource-constrained organization where the Asset Leader is expected to build capability
The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus) and an annual long-term incentive award (e.g., equity). Prime Medicine offers a comprehensive Total Rewards package with robust health, financial, and wellness benefits—including medical, dental, vision, life insurance, a 401(k) match, and equity programs—along with generous paid time off, wellness days, and company-wide recharge breaks. Our commitment to employee well-being reflects our belief that when we care for our people, we strengthen our ability to put patients first and make meaningful impact together.
U.S. Pay Range $360,000—$408,000 USD
Prime Medicine is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, sexual orientation, gender identity, disability, veteran status, or any other classification protected by law.
See all 10,403+ Green Card Product Development Intern Jobs
Sign up for free to unlock all listings, filter by visa type, and get alerts for new Green Card Product Development Intern Jobs.
Get Access To All JobsTips for Finding Green Card Sponsorship as a Product Development Intern
Document your technical credentials before applying
Gather transcripts, degree certificates, and any design or engineering coursework portfolios now. PERM labor certification requires your employer to verify your qualifications meet the position's minimum requirements, and gaps in documentation slow the process significantly.
Search for employers with active PERM filings
Use the OFLC Wage Search to identify companies that have filed PERM applications for product development or related roles. Employers already running PERM cases for similar positions have the legal infrastructure and employer-side willingness to sponsor again.
Target R&D-intensive companies over early-stage startups
Large consumer goods, medical device, and technology manufacturers are far more likely to sponsor interns for green cards than seed-stage startups, which typically lack the HR and legal resources required to manage a multi-year PERM process.
Clarify sponsorship intent before accepting an offer
Ask directly during the offer stage whether the company has sponsored interns or junior employees for EB-2 or EB-3 before. A hiring manager who can name a specific case is a stronger signal than a recruiter who says sponsorship is theoretically possible.
Use Migrate Mate to filter green card sponsoring employers
Search Migrate Mate specifically for Product Development Intern roles tied to verified sponsorship history. Filtering by green card sponsorship at this stage saves you from applying to employers who only support H-1B visa and have no PERM experience for early-career positions.
Understand how EB-3 priority dates affect your timeline
EB-3 is the most common category for intern-level roles, and your country of birth determines your wait time. Check the USCIS Visa Bulletin to understand whether your priority date is current before evaluating a sponsorship offer.
Green Card Product Development Intern: Frequently Asked Questions
Can a Product Development Intern position qualify for green card sponsorship?
Yes, but it requires the employer to classify the role as a permanent position requiring at least a bachelor's degree in a specific field. Intern titles can qualify under EB-3 if the job duties and minimum requirements meet DOL and USCIS standards. Companies in medical devices, consumer electronics, and manufacturing are most likely to have existing PERM processes for these roles.
How does green card sponsorship differ from H-1B for this role?
H-1B is a temporary status with an annual cap and lottery, while EB-2 and EB-3 green card sponsorship leads to permanent residency with no lottery risk. The PERM process takes longer upfront, often 18 to 36 months from filing to approval, but your residency is not tied to a specific employer once you reach the I-485 stage under portability rules.
What does PERM labor certification actually require from my employer?
Your employer must run a DOL-supervised recruitment process to demonstrate no qualified U.S. workers applied for the role. This includes specific job postings, documentation of all applicants reviewed, and a prevailing wage determination filed with DOL. The employer bears the legal and administrative burden, but you need to ensure your credentials match the posted minimum requirements exactly.
How do I find Product Development Intern jobs with green card sponsorship?
Migrate Mate lets you filter specifically for employers with verified green card sponsorship history, including PERM filings for product development roles. This removes the guesswork of cold-applying to companies that only sponsor H-1B transfers and have never filed PERM for an intern or junior-level product role.
Does my country of birth affect my EB-3 green card wait time for this role?
Yes. If you were born in India or China, EB-3 priority date backlogs can extend your wait by a decade or more. Nationals from most other countries face significantly shorter waits and sometimes current priority dates. Check the USCIS Visa Bulletin monthly to track your category and understand when you can file for adjustment of status.